Covid-19 Pharma News
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more. Read more
26 Feb 2024
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate. Read more
15 Feb 2024
Virios Therapeutics to Develop Long Covid Therapy
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with long covid. Read more
24 Jan 2024
African Vaccine Manufacturing Accelerator Make Up $1 Billion To Support Sustainable Vaccine Manufacturing In Africa
The Board of Gavi, the Vaccine Alliance today announced a series of decisions that will help lower-income countries tackle backsliding from the COVID-19 pandemic and be better prepared to respond to future health emergencies. Read more
12 Dec 2023
WHO Authorise Emergency Use of Novavax Protein-based COVID-19 Vaccine
Novavax Inc have announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19. Read more
28 Nov 2023
Biophytis and Innovation Solutions Pharma Sign Partnership
Biophytis SA announces the signature of a partnership with Innovation Solutions Pharma, a company specialising in support for clinical development and drug registration operations in South America. Read more
30 Oct 2023
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks. Read more
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics. Read more
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics. Read more
26 Jul 2022
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
NVIDIA and Cognizant Announce AI Pharma Partnership
Cognizant is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex challenges of drug discovery in the life sciences industry. Read more
19 Mar 2024
Vicore Announces FDA Breakthrough Device Designation for Almee
Vicore Pharma Holding AB have announced FDA Breakthrough Device Designation status for Almee, a 9-week digital cognitive behavioural therapy (CBT), to be used as an adjunct treatment of anxiety symptoms related to PF. Read more
19 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Orchard Therapeutics Receives FDA Approval of Lenmeldy
Orchard Therapeutics, recently acquired by Kyowa Kirin, have announced the U.S. FDA has approved Lenmeldy for the treatment of children with early-onset—metachromatic leukodystrophy. Read more
19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca
Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, have announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bluebird Bio Secures up to $175 Million Debt Financing
Bluebird Bio has entered into a $175 million five-year, term loan facility with Hercules Capital. The transaction strengthens the Company’s balance sheet as it executes on the commercial launches for its three FDA approved gene therapies. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25